Qualitative Exploration of Key Symptoms of Stricturing Crohn's Disease: Toward the Development of a Clinical Assessment Score.
SYMCROHNS
1 other identifier
observational
15
1 country
1
Brief Summary
The goal of this qualitative study is to identify and better understand the symptoms of stricturing Crohn's disease in order to inform the development of more appropriate clinical evaluation scores. This study focuses on adult patients diagnosed with stricturing Crohn's disease who are followed in hospital gastroenterology departments. The main questions it aims to answer are:
- Which symptoms are perceived by patients as the most specific and significant features of stenosing Crohn's disease?
- Which symptoms are perceived by patients as early warning signs of a stenosing flare?
- How does stenosing Crohn's disease impact daily life, mental health, and quality of life, and what coping strategies do patients use to manage symptoms and limit their impact? Participants will:
- Take part in a one-hour individual semi-structured interview, conducted in person (at the hospital, at home, or in another agreed location) or by videoconference
- Have the interview audio-recorded for transcription and qualitative analysis
- Be offered the opportunity to review and validate the transcript and summary of their interview before final anonymized analysis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
May 20, 2026
May 1, 2026
4 months
February 16, 2026
May 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency of patient-reported symptom categories associated with stenosing Crohn's disease, derived from thematic content analysis of single semi-structured interviews.
Up to 5 months
Secondary Outcomes (5)
Frequency of patient-reported symptom categories described as early warning signs of a stenosing flare, derived from qualitative content analysis of individual interviews.
Up to 5 months
Frequency of patient-reported daily life impact domains identified through qualitative content analysis of individual interviews.
Up to 5 months
Frequency of patient-reported mental health impact domains identified through qualitative content analysis of individual interviews.
Up to 5 months
Frequency of patient-reported quality-of-life impact domains identified through qualitative content analysis of single semi-structured interviews.
Up to 5 months
Frequency of patient-reported coping strategy categories identified through qualitative content analysis of individual interviews.
Up to 5 months
Interventions
One-hour semi-structured interview in person or by videoconference. Interviews will be audio-recorded, pseudonymized, transcribed, and analyzed, and participants can review their transcripts before final anonymization.
Eligibility Criteria
Adult patient (≥ 18 years old), with a confirmed diagnosis of Crohn's disease presenting a stricturing form of the disease
You may qualify if:
- Adult patient (≥ 18 years old).
- With a confirmed diagnosis of Crohn's disease.
- Presenting a stricturing form of the disease (confirmed clinically, endoscopically, radiologically, or surgically).
- Followed in a hospital department managing inflammatory bowel diseases (IBD).
- Clinically stable at the time of the interview (not experiencing an acute episode requiring urgent hospitalization).
- Able to understand and speak French, in order to participate in a qualitative interview.
You may not qualify if:
- Current hospitalization for a severe Crohn's disease flare, acute intestinal obstruction, or any situation requiring urgent medical care.
- Severe cognitive impairment, communication deficits, or acute psychiatric disorder preventing understanding of the interview or reliable expression of experiences.
- Major uncontrolled medical comorbidity (e.g., active cancer under treatment, severe heart failure) making the interview inappropriate or likely to confound symptom interpretation.
- Technical inability to participate in an interview (no access to the proposed modalities: unable to travel, no access to videoconference if a remote interview is required).
- Pregnant women
- Persons deprived of their liberty
- Persons receiving psychiatric care
- Persons admitted to a healthcare or social institution
- Adults subject to a legal protection measure
- Persons unable to express their consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Grenoble Alpes
La Tronche, 38700, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2026
First Posted
March 2, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
May 20, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared due to the qualitative nature of the study. The data consist of interview transcripts containing health-related information and sensitive personal content. Full anonymization cannot be guaranteed, and data sharing was not covered by the informed consent or the European regulatory framework (GDPR) applicable to this study.